PureTech Launches Seaport Therapeutics With $100M Oversubscribed Series A; Daphne Zohar Steps Down To Lead Seaport; Bharatt Chowrira Appointed New CEO
PureTech Launches Seaport Therapeutics With $100M Oversubscribed Series A; Daphne Zohar Steps Down To Lead Seaport; Bharatt Chowrira Appointed New CEO
PureTech推出海港療法，A輪超額認購1億美元；達芙妮·佐哈爾卸任海港負責人；巴拉特·喬里拉被任命爲新首席執行官
- Bharatt Chowrira, Ph.D., J.D., named Chief Executive Officer of PureTech; PureTech Co-founder, Eric Elenko, Ph.D., promoted to President
- PureTech Founding Chief Executive Officer, Daphne Zohar, to lead Seaport as Chief Executive Officer, together with former Karuna Chief Executive Officer and Chair, Steven M. Paul, M.D., as Chairman
- 巴拉特·喬里拉博士、法學博士被任命爲PureTech首席執行官；PureTech聯合創始人埃裏克·埃倫科博士晉升爲總裁
- PureTech 創始首席執行官達芙妮·佐哈爾將領導海港擔任首席執行官，前卡魯納首席執行官兼主席、醫學博士史蒂芬·保羅擔任董事長
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。